BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24177755)

  • 1. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
    Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
    Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.
    Ghavami S; Rashedi I; Dattilo BM; Eshraghi M; Chazin WJ; Hashemi M; Wesselborg S; Kerkhoff C; Los M
    J Leukoc Biol; 2008 Jun; 83(6):1484-92. PubMed ID: 18339893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑185‑5p inhibits F‑actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE.
    Yin C; Zhang G; Sun R; Pan X; Wang X; Li H; Sun Y
    Mol Med Rep; 2018 Sep; 18(3):2621-2630. PubMed ID: 30015912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
    Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
    Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
    Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
    Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
    Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y
    Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE.
    Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K
    J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.
    Ghavami S; Kerkhoff C; Chazin WJ; Kadkhoda K; Xiao W; Zuse A; Hashemi M; Eshraghi M; Schulze-Osthoff K; Klonisch T; Los M
    Biochim Biophys Acta; 2008 Feb; 1783(2):297-311. PubMed ID: 18060880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment.
    Taub CJ; Lippman ME; Hudson BI; Blomberg BB; Diaz A; Fisher HM; Nahin ER; Lechner SC; Kwak T; Hwang GH; Antoni MH
    Cancer; 2019 May; 125(10):1717-1725. PubMed ID: 30633331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.
    Turovskaya O; Foell D; Sinha P; Vogl T; Newlin R; Nayak J; Nguyen M; Olsson A; Nawroth PP; Bierhaus A; Varki N; Kronenberg M; Freeze HH; Srikrishna G
    Carcinogenesis; 2008 Oct; 29(10):2035-43. PubMed ID: 18689872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
    Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.
    Kwon CH; Moon HJ; Park HJ; Choi JH; Park DY
    Mol Cells; 2013 Mar; 35(3):226-34. PubMed ID: 23456298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
    Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
    Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.
    Sakaguchi M; Murata H; Aoyama Y; Hibino T; Putranto EW; Ruma IM; Inoue Y; Sakaguchi Y; Yamamoto K; Kinoshita R; Futami J; Kataoka K; Iwatsuki K; Huh NH
    J Biol Chem; 2014 Aug; 289(34):23389-402. PubMed ID: 25002577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
    Tomonobu N; Kinoshita R; Sakaguchi M
    Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. exSSSRs (extracellular S100 soil sensor receptors)-Fc fusion proteins work as prominent decoys to S100A8/A9-induced lung tropic cancer metastasis.
    Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
    Int J Cancer; 2019 Jun; 144(12):3138-3145. PubMed ID: 30365872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.